Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo

PloS One
Margaret W GichaneMarcel Yotebieng

Abstract

Intimate partner violence (IPV) is a risk factor for non-adherence to HIV treatment for women, however the evidence on the impact of IPV on uptake of the prevention of mother to child transmission of HIV (PMTCT) cascade is inconclusive. We examined data from 433 HIV positive pregnant women in Kinshasa, Democratic Republic of Congo, enrolled between April 2013 and August 2014 and followed-up through 6 weeks postpartum. Participants were asked about their IPV experiences in a face-to-face interview at enrollment. Measures of PMTCT cascade included: uptake of clinical appointments and services, viral suppression, and adherence to antiretrovirals (ARV). Approximately half of the sample (51%) had experienced some form of IPV; 35% had experienced emotional abuse, 29% physical abuse, and 19% sexual abuse. There were no statistically significant associations between experiencing any form of IPV and uptake of clinical appointments and services (Adjusted Prevalence Ratio [aPR] = 1.02; 95% [CI]: 0.89-1.17), viral load suppression (aPR = 1.07, 95% CI:0.96-1.19) and ARV adherence (aPR = 1.01, 95% CI: 0.87-1.18). Findings from this study indicate that, among HIV-infected pregnant women enrolled in PMTCT care, experiencing IPV does not reduce...Continue Reading

References

Aug 8, 2002·Journal of Women's Health & Gender-based Medicine·Ann L CokerKeith E Davis
Feb 16, 2006·AIDS Patient Care and STDs·Bronwen Lichtenstein
Aug 26, 2006·AIDS·James N KiarieGrace C John-Stewart
Oct 10, 2006·Lancet·Claudia Garcia-MorenoUNKNOWN WHO Multi-country Study on Women's Health and Domestic Violence against Women Study Team
Nov 23, 2006·BMC Public Health·Charles A S KaramagiKristian Heggenhougen
Feb 11, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Michael C EzeanochieFriday E Okonofua
Jun 21, 2011·Maternal and Child Health Journal·Leslie Goo, Siobán D Harlow
Aug 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeffrey S GonzalezSteven A Safren
Feb 20, 2013·Scandinavian Journal of Psychology·I García-MoyaC Moreno
Feb 23, 2013·International Journal of Family Medicine·Gina DillonSaifur Rahman
Sep 30, 2014·Journal of Women's Health·Jeanne L AlhusenLinda Bullock
Oct 16, 2014·Journal of Interpersonal Violence·Sarah Myers Tlapek
Nov 6, 2014·Journal of the International AIDS Society·Abigail M HatcherClaudia García-Moreno
Mar 9, 2017·BMC Health Services Research·Bedru Hussen MohammedJemal Ali Haidar

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Clinical Trials Mentioned

NCT01838005

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.